Expertise in
64
conditions

Dr. Kofi W. Nuako

Gastroenterology
Kofi Nuako MD PC
1109 E Reelfoot Ave Ste C, 
Union City, TN 
Accepting New Patients
Referral may be required
Before you request
Expertise in
64
conditions
Kofi Nuako MD PC
1109 E Reelfoot Ave Ste C, 
Union City, TN 

Overview

Kofi Nuako is a Gastroenterologist practicing medicine in Union City, Tennessee.

Dr. Nuako is highly rated in 64 conditions, according to our data. His clinical expertise encompasses Esophagitis, Viral Gastroenteritis, Familial Adenomatous Polyposis, Colonoscopy, and Gastrectomy.

He is actively involved in clinical research, participating in 13 clinical trials. Dr. Nuako is currently accepting new patients.

Specialties

Gastroenterology

Licenses

Internal Medicine in TN

Hospital Affiliations

Volunteer Community Hospital
Jackson-Madison County General Hospital
Dyersburg Regional Medical Center
Baptist Memorial Hospital - Carroll County
Baptist Memorial Hospital Union City

Languages Spoken

English
French

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Farm Bureau Health Plans
  • HMO
  • MEDICARE MAPD
  • MEDICARE PDP
Health Alliance
  • EPO
  • HMO
  • POS
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
Oscar
  • EPO
  • HMO
  • PPO
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 11 Less Insurance Carriers -

Locations

Kofi Nuako MD PC
1109 E Reelfoot Ave Ste C, Union City, TN 38261

Additional Areas of Focus

Dr. Nuako has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Non-Alcoholic Fatty Liver Disease
Nonalcoholic Steatohepatitis (NASH)

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

12 Clinical Trials

Evaluation of the ctDNA LUNAR Test in an Average Patient Screening Episode
Evaluation of the ctDNA LUNAR Test in an Average Patient Screening Episode
Enrollment Status: Active_not_recruiting
Publish Date: May 14, 2026
A Phase 2, Randomized, Double-Blind, Comparator-Controlled, Multicenter Study to Evaluate the Safety and Efficacy of CRS3123 Compared With Oral Vancomycin in Adults With Clostridioides Difficile Infection
A Phase 2, Randomized, Double-Blind, Comparator-Controlled, Multicenter Study to Evaluate the Safety and Efficacy of CRS3123 Compared With Oral Vancomycin in Adults With Clostridioides Difficile Infection
Enrollment Status: Completed
Publish Date: March 27, 2026
Intervention Type: Drug
Study Drug: CRS3123
Study Phase: Phase 2
Blood and Stool Sample Collection in Subjects With a Diagnosis of Colorectal Cancer or Colorectal Lesion: Act Fast
Blood and Stool Sample Collection in Subjects With a Diagnosis of Colorectal Cancer or Colorectal Lesion: Act Fast
Enrollment Status: Completed
Publish Date: June 29, 2025
A Phase 3 Long-term Safety Extension Study of SHP647 in Subjects With Moderate to Severe Ulcerative Colitis or Crohn's Disease (AIDA)
A Phase 3 Long-term Safety Extension Study of SHP647 in Subjects With Moderate to Severe Ulcerative Colitis or Crohn's Disease (AIDA)
Enrollment Status: Completed
Publish Date: June 21, 2024
Intervention Type: Drug
Study Drug: Ontamalimab
Study Phase: Phase 3
Blood Collection Sub-Study of Exact Sciences Protocol 2019-01: Clinical Validation of an Optimized Multi-Target Stool DNA (Mt-sDNA 2.0) Test, For Colorectal Cancer Screening BLUE-C
Blood Collection Sub-Study of Exact Sciences Protocol 2019-01: Clinical Validation of an Optimized Multi-Target Stool DNA (Mt-sDNA 2.0) Test, For Colorectal Cancer Screening BLUE-C
Enrollment Status: Completed
Publish Date: September 28, 2023
Intervention Type: Other
Clinical Validation of An Optimized Multi-Target Stool DNA (Mt-sDNA 2.0) Test, for Colorectal Cancer Screening BLUE-C
Clinical Validation of An Optimized Multi-Target Stool DNA (Mt-sDNA 2.0) Test, for Colorectal Cancer Screening BLUE-C
Enrollment Status: Completed
Publish Date: September 01, 2023
Intervention Type: Procedure, Diagnostic test
A Phase 2, Multicenter, Randomized, Parallel-Arm, Placebo-Controlled Study of LY3074828 in Subjects With Active Crohn's Disease (SERENITY)
A Phase 2, Multicenter, Randomized, Parallel-Arm, Placebo-Controlled Study of LY3074828 in Subjects With Active Crohn's Disease (SERENITY)
Enrollment Status: Completed
Publish Date: August 30, 2022
Intervention Type: Drug
Study Drug: Mirikizumab
Study Phase: Phase 2
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Maintenance Therapy in Subjects With Moderate to Severe Crohn's Disease (CARMEN CD 307)
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Maintenance Therapy in Subjects With Moderate to Severe Crohn's Disease (CARMEN CD 307)
Enrollment Status: Terminated
Publish Date: March 31, 2022
Intervention Type: Drug, Other
Study Drug: Ontamalimab
Study Phase: Phase 3
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Maintenance Therapy in Subjects With Moderate to Severe Ulcerative Colitis (FIGARO UC 303)
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Maintenance Therapy in Subjects With Moderate to Severe Ulcerative Colitis (FIGARO UC 303)
Enrollment Status: Completed
Publish Date: January 14, 2022
Intervention Type: Other, Drug
Study Phase: Phase 3
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Induction Therapy in Subjects With Moderate to Severe Ulcerative Colitis (FIGARO UC 301)
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Induction Therapy in Subjects With Moderate to Severe Ulcerative Colitis (FIGARO UC 301)
Enrollment Status: Terminated
Publish Date: June 14, 2021
Intervention Type: Other, Drug
Study Phase: Phase 3
View 9 Less Clinical Trials
Similar Doctors
Expertise in
48
conditions
Dr. Bob T. Souder
Gastroenterology
Expertise in
48
conditions
Dr. Bob T. Souder
Gastroenterology
Referral may be required

Tennessee Anesthesia Network Services LLC

9 Physicians Dr, 
Jackson, TN 
 (53.6 miles away)
731-661-0086
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Bob Souder is a Gastroenterologist practicing medicine in Jackson, Tennessee. Dr. Souder is highly rated in 48 conditions, according to our data. His clinical expertise encompasses Non-Alcoholic Fatty Liver Disease, Gastroesophageal Reflux Disease (GERD), Visceromegaly, Enlarged Liver, and Endoscopy. Dr. Souder is currently accepting new patients.

Expertise in
28
conditions
Dr. Babu V. Rao
Gastroenterology
Expertise in
28
conditions
Dr. Babu V. Rao
Gastroenterology
Referral may be required

Methodist Healthcare Alliance

420 Wilkinson Dr, 
Dyersburg, TN 
 (30.1 miles away)
731-285-5133
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Babu Rao is a Gastroenterologist practicing medicine in Dyersburg, Tennessee. Dr. Rao is highly rated in 28 conditions, according to our data. His clinical expertise encompasses Hiatal Hernia, Congenital Diaphragmatic Hernia, Non-Alcoholic Fatty Liver Disease, Endoscopy, and Gastrostomy. Dr. Rao is currently accepting new patients.

Expertise in
38
conditions
Dr. Timothy E. Shiben
Gastroenterology
Expertise in
38
conditions
Dr. Timothy E. Shiben
Gastroenterology
Referral may be required

Office

2605 Kentucky Ave Ste 202, 
Paducah, KY 
 (49.6 miles away)
270-415-4690
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Timothy Shiben is a Gastroenterologist practicing medicine in Paducah, Kentucky. Dr. Shiben is highly rated in 38 conditions, according to our data. His clinical expertise encompasses Familial Adenomatous Polyposis, Turcot Syndrome, Gardner Syndrome, Endoscopy, and Gastrostomy. Dr. Shiben is currently accepting new patients.

Frequently Asked Questions about Dr. Kofi W. Nuako

How do I make an appointment with Dr. Kofi W. Nuako?

You can book an appointment with Dr. Kofi W. Nuako by calling their office at 731-884-0600. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Kofi W. Nuako a top-rated expert for Esophagitis?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Kofi W. Nuako is classified as an Distinguished expert for Esophagitis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Kofi W. Nuako specialize in?

While Dr. Kofi W. Nuako is a Gastroenterology, they have specific expertise in Esophagitis, Viral Gastroenteritis, and Familial Adenomatous Polyposis. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Gastroenterology.

Does Dr. Kofi W. Nuako accept my insurance?

Dr. Kofi W. Nuako accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 731-884-0600 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Nuako's expertise for a condition
ConditionClose
    View All 22 Distinguished Conditions
    View All 42 Advanced Conditions
    View All 55 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile